APOE and metabolic disease: As shown in Fig. 10, our study demonstrates that ZXYF alleviated HFD caused intestinal barrier damage and cholesterol metabolism disorders by maintaining gut microbiota homeostasis and gut microbiome metabolism in ApoE−/− mice.